• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

立体定向体部放射治疗局部复发性中央型非小细胞肺癌导致的延迟性食管穿孔。

Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer.

作者信息

Sainathan Sandeep, Wu Leester D, Andaz Shahriyour

机构信息

Department of Surgery, Bronx-Lebanon Hospital Center, Bronx, New York 10457, USA.

Department of Radiation Oncology, South Nassau Communities Hospital, Oceanside, New York 11572, USA.

出版信息

Lung India. 2014 Apr;31(2):158-60. doi: 10.4103/0970-2113.129854.

DOI:10.4103/0970-2113.129854
PMID:24778482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3999679/
Abstract

Stereotactic body radiation therapy (SBRT) is a novel form of external beam radiation therapy. It is used to treat early and locally recurrent nonsmall cell lung cancer (NSLC) in medically inoperable patients. It uses high dose, hypofractionated radiotherapy, with targeting of the tumor by precise spatial localization, thus minimizing injury to surrounding tissues. It can be safely used to ablate NSLC in both central and peripheral locations. We present two cases of delayed esophageal perforation after SBRT for locally recurrent central NSLC. The perforations occurred several months after the therapy. They were treated with covered esophageal stents, with mortality, due to the perforation in one of the patients. SBRT should be judiciously used to ablate centrally located NSLC and patients who develop episodes of esophagitis during or after SBRT, need to be closely followed with endoscopy to look for esophageal ulcerations. These ulcers should be closely followed for healing as these may degenerate into full thickness perforations several months after SBRT.

摘要

立体定向体部放射治疗(SBRT)是一种新型的外照射放射治疗形式。它用于治疗医学上无法手术的早期和局部复发性非小细胞肺癌(NSLC)患者。它采用高剂量、低分割放疗,通过精确的空间定位靶向肿瘤,从而将对周围组织的损伤降至最低。它可安全用于消融中央型和周围型NSLC。我们报告了两例因SBRT治疗局部复发性中央型NSLC后发生延迟性食管穿孔的病例。穿孔发生在治疗后数月。患者接受了覆膜食管支架治疗,其中一名患者因穿孔死亡。应谨慎使用SBRT消融中央型NSLC,并且在SBRT期间或之后发生食管炎的患者,需要密切进行内镜检查以寻找食管溃疡。应密切观察这些溃疡的愈合情况,因为在SBRT后数月它们可能恶化为全层穿孔。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe83/3999679/54ed9a618f77/LI-31-158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe83/3999679/ec7990606bc3/LI-31-158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe83/3999679/54ed9a618f77/LI-31-158-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe83/3999679/ec7990606bc3/LI-31-158-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe83/3999679/54ed9a618f77/LI-31-158-g002.jpg

相似文献

1
Delayed esophageal perforation from stereotactic body radiation therapy for locally recurrent central nonsmall cell lung cancer.立体定向体部放射治疗局部复发性中央型非小细胞肺癌导致的延迟性食管穿孔。
Lung India. 2014 Apr;31(2):158-60. doi: 10.4103/0970-2113.129854.
2
Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.加速超分割放疗与立体定向体部放疗治疗Ⅰ期非小细胞肺癌——单机构长期随访经验
Technol Cancer Res Treat. 2018 Jan 1;17:1533033818806318. doi: 10.1177/1533033818806318.
3
Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.适形调强立体定向体部放疗用于紧邻中央大气道的医学上无法手术的Ⅰ期肺癌
Lung Cancer. 2009 Oct;66(1):89-93. doi: 10.1016/j.lungcan.2008.12.016. Epub 2009 Jan 24.
4
Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.立体定向体部放疗和立体定向体部质子治疗高危、不可手术、早期非小细胞肺癌的 2 期研究。
Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):558-563. doi: 10.1016/j.ijrobp.2018.02.022. Epub 2018 Mar 2.
5
[Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer].[立体定向体部放射治疗中央型非小细胞肺癌]
Zhongguo Fei Ai Za Zhi. 2018 May 20;21(5):413-418. doi: 10.3779/j.issn.1009-3419.2018.05.10.
6
Complications from Stereotactic Body Radiotherapy for Lung Cancer.立体定向体部放疗治疗肺癌的并发症
Cancers (Basel). 2015 Jun 15;7(2):981-1004. doi: 10.3390/cancers7020820.
7
Surgical treatment of esophageal perforation after stereotactic body radiotherapy: A report of two cases.立体定向体部放疗后食管穿孔的外科治疗:两例报告
Int J Surg Case Rep. 2023 Jan;102:107805. doi: 10.1016/j.ijscr.2022.107805. Epub 2022 Nov 30.
8
Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.加拿大针对I期医学上无法手术的非小细胞肺癌开展的立体定向体部放疗与传统低分割放疗的III期随机试验——安大略临床肿瘤学组(OCOG)-LUSTRE试验的原理与方案设计
Clin Lung Cancer. 2017 Mar;18(2):250-254. doi: 10.1016/j.cllc.2016.08.002. Epub 2016 Oct 3.
9
Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.食管癌对立体定向体部放疗大分割照射的剂量耐受性:晚期毒性的危险因素。
Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):197-202. doi: 10.1016/j.ijrobp.2014.05.011. Epub 2014 Jul 8.
10
Guideline for radiotherapy with curative intent in patients with early-stage medically inoperable non-small-cell lung cancer.早期医学上无法手术的非小细胞肺癌患者根治性放疗指南
Curr Oncol. 2017 Feb;24(1):e44-e49. doi: 10.3747/co.24.3358. Epub 2017 Feb 27.

引用本文的文献

1
Chinese clinical practice guidelines for the prevention and treatment of radiation-induced esophagitis.放射性食管炎防治的中国临床实践指南
Precis Radiat Oncol. 2023 Sep 20;7(4):225-236. doi: 10.1002/pro6.1210. eCollection 2023 Dec.
2
Is lung stereotactic ablative radiotherapy safe after pneumonectomy?-a systematic review.肺切除术后进行肺部立体定向消融放疗是否安全?一项系统综述
Transl Lung Cancer Res. 2020 Apr;9(2):348-353. doi: 10.21037/tlcr.2020.01.18.
3
Contrast enhanced oesophageal avoidance for stereotactic body radiotherapy: Barium vs. Gastrografin.

本文引用的文献

1
Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.四维立体定向放疗治疗中央型肺部肿瘤的结果。
Radiother Oncol. 2012 Mar;102(3):383-7. doi: 10.1016/j.radonc.2011.12.023. Epub 2012 Jan 20.
2
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.立体定向体部放射治疗用于治疗中心型和位于上部的I期或孤立复发性非小细胞肺癌。
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):967-71. doi: 10.1016/j.ijrobp.2008.08.001.
3
Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.
立体定向体部放疗中对比剂增强食管避让:钡剂与泛影葡胺的比较
Tech Innov Patient Support Radiat Oncol. 2019 Dec 16;12:16-22. doi: 10.1016/j.tipsro.2019.10.004. eCollection 2019 Dec.
4
Comparison of single- and five-fraction schedules of stereotactic body radiation therapy for central lung tumours: a single institution experience.立体定向体部放射治疗中央型肺肿瘤的单次分割与五次分割方案比较:单机构经验
J Radiother Pract. 2017 Jun;16(2):148-154. doi: 10.1017/S1460396917000061. Epub 2017 May 8.
5
A surgical case of radiotherapy induced esophageal perforation accompanying pyogenic spondylodiscitis: a case report.1例放疗诱发食管穿孔伴化脓性椎间盘炎的外科病例:病例报告
Surg Case Rep. 2017 Aug 31;3(1):98. doi: 10.1186/s40792-017-0368-1.
在一项针对医学上无法手术的早期肺癌进行立体定向体部放射治疗的II期研究中,治疗中央型肿瘤时毒性过大。
J Clin Oncol. 2006 Oct 20;24(30):4833-9. doi: 10.1200/JCO.2006.07.5937.
4
Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer.颅外立体定向放射消融:I期研究在医学上无法手术的I期非小细胞肺癌中的结果。
Chest. 2003 Nov;124(5):1946-55. doi: 10.1378/chest.124.5.1946.
5
The role of radiotherapy in treatment of stage I non-small cell lung cancer.放射治疗在Ⅰ期非小细胞肺癌治疗中的作用。
Lung Cancer. 2003 Jul;41(1):1-11. doi: 10.1016/s0169-5002(03)00152-1.
6
Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.原发性和转移性肺癌小体积、大分割、图像引导放射治疗中危及器官的耐受性
Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):126-35. doi: 10.1016/s0360-3016(03)00095-6.
7
Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer.
Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):119-130. doi: 10.1016/s0360-3016(02)02917-6.